Open AccessACTR-62. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP
Neuro-oncologyPeer ReviewedTomokazu Aoki +92018Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support